iveenamed.com
Contact us
About company
iVeena has five products in the late pre-clinical and research phases. Targeted indications include post-surgery cataract inflammation, macular degeneration (Wet AMD), diabetic retinopathy and glaucoma.
US
Unknown
Unknown
Not verified company
